Keywords
Anesthesia
Physiology
Pharmacology
Complications of ECT
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: Approach the main anesthesia care measures for patients undergoing ECT. Literature review: Based on the assumption that schizophrenic patients who suffered from convulsions showed improvement in psychotic symptoms, and the post-mortem observation of an increase (beyond expectations) in the concentration of glial cells in epileptic patients and a reduction in schizophrenic patients, it was postulated that convulsions would have therapeutic effects. Several methods of convulsion induction were developed, initially using drugs, which produced variable therapeutic results with numerous side effects. Later, in the 1930s, with the use of electricity, more precise results were obtained with greater patient safety. Final considerations: The advent of anesthesia made the procedure even safer, more humane, effective and better tolerated. More recently, the indications for ECT have been expanded, making it imperative that the professionals involved have knowledge of the physiological responses, drug interactions, possible complications and contraindications of ECT.
References
ABOU-SALEH M, et al. Eletroconvulsoterapia: critérios e recomendações da Associação Mundial de Psiquiatria. Revista de Psiquiatria Clínica, São Paulo, 2004; 31(5): 263-268.
AKHTAR SM, et al. Beyond the surface: analyzing etomidate and propofol as anesthetic agents in electroconvulsive therapy—A systematic review and meta-analysis of seizure duration outcomes. Frontiers in Neurology, 2023; 14: 1251882.
AOKI N, et al. Sevoflurane in electroconvulsive therapy: A systematic review and meta-analysis of randomised trials. Journal of psychiatric research, 2021; 141: 16-25.
CASTELLI I, et al. Comparative effects of esmolol and labetalol to attenuate hyperdynamic states after electroconvulsive therapy. Anesthesia & Analgesia,1995; 80(3): 557-561.
CHAWLA N. Anesthesia for electroconvulsive therapy. Anesthesiology Clinics, 2020; 38(1): 183-195.
DAI X, et al. Anesthetic Influence on Electroconvulsive Therapy: A Comprehensive Review. Neuropsychiatric Disease and Treatment, 2024; 1491-1502.
DEINER S, et al. Electroconvulsive therapy and anesthesia. International anesthesiology clinics, 2009; 47(2): 81-92.
DELVA NJ, et al. Electrical dose and seizure threshold: relations to clinical outcome and cognitive effects in bifrontal, bitemporal, and right unilateral ECT. The journal of ECT, 2020; 16(4): 361-369.
DING Z, et al. Anesthesia for electroconvulsive therapy. Anesthesia & Analgesia,2002; 94 (5): 1351-1364.
FOLK JW, et al. Anesthesia for electroconvulsive therapy: a review. J ECT 2000; 16: 157–70.
FU W, et al. Acute hemodynamic responses to electroconvulsive therapy are not related to the duration of seizure activity. Journal of clinical anesthesia,1997; 9(8): 653-657.
GAINES GY e REES DI. Electroconvulsive therapy and anesthetic considerations. Anesthesia & Analgesia,1986; 65(12): 1345-1356.
GERLACH AT, et al. Dexmedetomidine: an updated review. Annals of Pharmacotherapy,2007; 41(2): 245-254.
GUREL SC, et al. The superiority of ketofol and etomidate against propofol or thiopental anesthesia for ECT. Asian Journal of Psychiatry, 2022; 72: 103090.
HERMIDA AP, et al. The cardiovascular side effects of electroconvulsive therapy and their management. The Journal of ECT,2022; 38(1): 2-9.
JOUNG KW, et al. Anesthetic care for electroconvulsive therapy. Anesthesia and Pain Medicine, 2022; 17(2): 145-156.
KELLNER CH, et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Archives of general psychiatry,2006; 63(12): 1337-1344.
KHAN A, et al. Electroconvulsive therapy. Psychiatric Clinics of North America, 1993; 16 (3): 497-513.
LAVA-PARMELE S, et al. The historical struggles of modified electroconvulsive therapy: how anesthesia came to the rescue. Journal of anesthesia history, 2021; 7(2): 17-25.
LEE K, et al. A narrative overview of current anesthetic drugs in electroconvulsive therapy. Life, 2021; 11(9): 981.
LOPEZ-GOMEZ D, et al. Myocardial infarction after electroconvulsive therapy. Revista española de cardiología,1999; 52(7): 536-536.
MAIXNER D, et al. Electroconvulsive therapy is an essential procedure. American Journal of Psychiatry,2021; 178(5): 381-382.
MAYUR PM, et al. Acute post-ECT cardiovascular response: a comparison of threshold right unilateral and bilateral ECT. The Journal of ECT, 1998; 14(2): 94-98.
NG C, et al. Efficacy and cognitive effects of right unilateral electroconvulsive therapy. The Journal of ECT, 2000; 16 (4): 370-379.
NIKOLIN S, et al. Comparison of site localization techniques for brain stimulation. The Journal of ECT, 2019; 35(2): 127-132.
PRUDIC J, et al. Effectiveness of electroconvulsive therapy in community settings. Biological psychiatry, 2004; 55(3): 301-312.
RIKHER KV, et al. Cortical blindness after electroconvulsive therapy. The Journal of the American Board of Family Practice, 1997; 10(2): 141-143.
SAITO S, et al. Reduction of cerebral hyperemia with anti-hypertensive medication after electroconvulsive therapy. Canadian Journal of Anesthesia, 2000; 47: 767-774.
SAITO S, et al. Regional cerebral oxygen saturation during electroconvulsive therapy: monitoring by near-infrared spectrophotometry. Anesthesia & Analgesia, 1996; 83(4): 726-730.
SEGMAN RH, et al. Onset and time course of antidepressant action: psychopharmacological implications of a controlled trial of electroconvulsive therapy. Psychopharmacology, 1995; 119: 440-448.
SEMKOVSKA M, et al. Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biological psychiatry, 2010; 68 (6): 568-577.
SOEHLE M, et al. Challenges and pitfalls in anesthesia for electroconvulsive therapy. Best Practice & Research Clinical Anaesthesiology, 2021; 35 (2): 181-189.
SURVE RM, et al. Electroconvulsive therapy services during COVID-19 pandemic. Asian Journal of Psychiatry, 2021; 59: 102653.
SWARTZ CM. Physiological response to ECT stimulus dose. Psychiatry research, 2000; 97(2-3): 229-235.
TAJABADI N, et al. The Effects of Remifentanil, Dexmedetomidine, and Metoral as Adjuncts to Thiopental on Hemodynamic Status After Electroconvulsive Therapy in Patients with Major Depressive Disorder: A Randomized Controlled Clinical Trial. Anesthesiology and Pain Medicine, 2023; 13(5).
TAKEKITA Y, et al. Remifentanil in electroconvulsive therapy: a systematic review and meta-analysis of randomized controlled trials. European archives of psychiatry and clinical neuroscience, 2016; 266: 703-717.
WEINER RD. American Psychiatric Association committee on electroconvulsive therapy. The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging, 2001; 2: 1040-41.
WEINGER MB, et al. Prevention of the cardiovascular and neuroendocrine response to electroconvulsive therapy: II. Effects of pretreatment regimens on catecholamines, ACTH, vasopressin, and cortisol. Anesthesia & Analgesia, 1991; 73 (5): 563-569.
WEISBERG LA, et al. Intracerebral hemorrhage following electroconvulsive therapy. Neurology, 1991.
ZACHRISSON OG, et al. No evident neuronal damage after electroconvulsive therapy. Psychiatry research, 2000; 96 (2): 157-165.